MANAGEMENT OF HYPERSENSITIVITY REACTIONS TO ANTITUBERCULOSIS DRUGS

被引:10
|
作者
THOMPSON, JE
机构
关键词
D O I
10.5694/j.1326-5377.1969.tb107598.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:1058 / &
相关论文
共 50 条
  • [42] Hypersensitivity reactions to platinum drugs and taxanes
    Andriollo, G.
    Buonomo, A.
    Aruanno, A.
    Nucera, E.
    ALLERGY, 2020, 75 : 218 - 218
  • [43] Hypersensitivity reactions to antiepileptic drugs in children
    Atanaskovic-Markovic, Marina
    Jankovic, Jelena
    Tmusic, Vladimir
    Gavrovic-Jankulovic, Marija
    Velickovic, Tanja Cirkovic
    Nikolic, Dimitrije
    Skoric, Dejan
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2019, 30 (05) : 547 - 552
  • [45] Hypersensitivity reactions to small molecule drugs
    Han, Jiayin
    Pan, Chen
    Tang, Xuan
    Li, Qi
    Zhu, Yan
    Zhang, Yushi
    Liang, Aihua
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [46] Advances in the understanding of hypersensitivity reactions to drugs
    Thong, Bernard
    Blanca, Miguel
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 9 (04) : 291 - 292
  • [47] Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer
    Ruggiero, Antonio
    Triarico, Silvia
    Trombatore, Giovanna
    Battista, Andrea
    Dell'Acqua, Fabiola
    Rizzari, Carmelo
    Riccardi, Riccardo
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (10) : 1739 - 1746
  • [48] Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer
    Antonio Ruggiero
    Silvia Triarico
    Giovanna Trombatore
    Andrea Battista
    Fabiola Dell’Acqua
    Carmelo Rizzari
    Riccardo Riccardi
    European Journal of Clinical Pharmacology, 2013, 69 : 1739 - 1746
  • [49] ANTITUBERCULOSIS DRUGS
    GARAGUSI, V
    AMERICAN FAMILY PHYSICIAN, 1972, 5 (04) : 133 - &
  • [50] Analysis of Cases of Hepatic Adverse Reactions with Antituberculosis Drugs in Morocco
    Smaili, I.
    Soulaymani, R.
    Tebaa, A.
    DRUG SAFETY, 2018, 41 (11) : 1259 - 1259